Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001317757-11-000019)

Filing Details

Accession Number:: 0001317757-11-000019
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2011-06-01 16:35:14
Reporting Period:: 2011-05-31

Filing Date:: 2011-06-01
Accepted Time:: 2011-06-01 16:35:14
Original Submission Date:: 2011-06-01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	Pharmaceutical Preparations (2834)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1296999	David Arkowitz	C/O Amag Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421	Evp, Cfo, Cbo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-05-31	1,500	$13.23	1,806	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Company is filing this Amended Form 4 to correct the closing date used to calculate the purchase price of the shares acquired by the reporting person. The correct date is December 1, 2010.